Elimelech  Rosner net worth and biography

Elimelech Rosner Biography and Net Worth

EVP / Chief Technology Officer of HealthEquity

With more than 25 years of business and technology leadership experience, Eli leads the Technology organization with a focus on security, unification, and simplification to create a better customer experience for more than 14 million members. Eli is responsible for all aspects of the HealthEquity technology strategy and driving innovation. Eli’s teams are dedicated to delivering modern and mature technology solutions to scale and digitally transform our business through AI, cloud, open APIs and open development platforms.

Prior to joining HealthEquity in 2022, Eli was Chief Product and Technology Officer at Finistra, one of the largest global providers of software to the financial services industry. There he was responsible for Product strategy, product management, platform strategy and architecture, to solutions development and data center operations. Immediately prior to Finistra, Eli served as CTO and Head of Product Management, driving the transformation from a hardware and services company to a global leader in platform, data and solutions for financial services, retail, and hospitality.

Eli received a B.A. and B.S. from Technion – Israel Institute of Technology.

What is Elimelech Rosner's net worth?

The estimated net worth of Elimelech Rosner is at least $7.15 million as of June 6th, 2025. Mr. Rosner owns 75,689 shares of HealthEquity stock worth more than $7,154,124 as of July 13th. This net worth evaluation does not reflect any other assets that Mr. Rosner may own. Additionally, Mr. Rosner receives a salary of $1,740,000.00 as EVP / Chief Technology Officer at HealthEquity. Learn More about Elimelech Rosner's net worth.

How old is Elimelech Rosner?

Mr. Rosner is currently 67 years old. There are 5 older executives and no younger executives at HealthEquity. Learn More on Elimelech Rosner's age.

What is Elimelech Rosner's salary?

As the EVP / Chief Technology Officer of HealthEquity, Inc., Mr. Rosner earns $1,740,000.00 per year. Learn More on Elimelech Rosner's salary.

How do I contact Elimelech Rosner?

The corporate mailing address for Mr. Rosner and other HealthEquity executives is 15 WEST SCENIC POINTE DRIVE SUITE 100, DRAPER UT, 84020. HealthEquity can also be reached via phone at (801) 727-1000 and via email at [email protected]. Learn More on Elimelech Rosner's contact information.

Has Elimelech Rosner been buying or selling shares of HealthEquity?

Elimelech Rosner has not been actively trading shares of HealthEquity within the last three months. Most recently, Elimelech Rosner sold 58,000 shares of the business's stock in a transaction on Friday, June 6th. The shares were sold at an average price of $112.56, for a transaction totalling $6,528,480.00. Following the completion of the sale, the executive vice president now directly owns 75,689 shares of the company's stock, valued at $8,519,553.84. Learn More on Elimelech Rosner's trading history.

Who are HealthEquity's active insiders?

HealthEquity's insider roster includes Edward Bloomberg (COO), Frank Corvino (Director), Adrian Dillon (Director), Evelyn Dilsaver (Director), Ashley Dreier (VP), Michael Fiore (EVP), Angelique Hill (VP), Jon Kessler (President, CEO & Director), Delano Ladd (EVP), Debra McCowan (Director), Darcy Mott (Insider), Tyson Murdock (Chief Financial Officer), Stephen Neeleman (Founder, Vice Chairman), William Otten (VP), Stuart Parker (Director), Elimelech Rosner (EVP / Chief Technology Officer), Ian Sacks (Director), Robert Selander (Director), Larry Trittschuh (EVP), and Gayle Wellborn (Director). Learn More on HealthEquity's active insiders.

Are insiders buying or selling shares of HealthEquity?

In the last twelve months, insiders at the sold shares 13 times. They sold a total of 390,911 shares worth more than $41,421,925.79. The most recent insider tranaction occured on July, 7th when EVP Michael Henry Fiore sold 1,794 shares worth more than $182,503.62. Insiders at HealthEquity own 1.5% of the company. Learn More about insider trades at HealthEquity.

Information on this page was last updated on 7/7/2025.

Elimelech Rosner Insider Trading History at HealthEquity

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/6/2025Sell58,000$112.56$6,528,480.0075,689View SEC Filing Icon  
12/11/2023Sell2,017$70.09$141,371.5362,898View SEC Filing Icon  
6/12/2023Sell10,156$64.29$652,929.2470,334View SEC Filing Icon  
See Full Table

Elimelech Rosner Buying and Selling Activity at HealthEquity

This chart shows Elimelech Rosner's buying and selling at HealthEquity by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

HealthEquity Company Overview

HealthEquity logo
HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. It also provides investment platform; and online-only automated investment advisory services through Advisor, a Web-based tool. In addition, the company offers flexible spending accounts; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. It serves clients through a direct sales force; benefits brokers and advisors; and a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. HealthEquity, Inc. was incorporated in 2002 and is based in Draper, Utah.
Read More

Today's Range

Now: $94.52
Low: $93.65
High: $96.78

50 Day Range

MA: $100.98
Low: $90.27
High: $113.06

2 Week Range

Now: $94.52
Low: $65.01
High: $116.65

Volume

1,106,970 shs

Average Volume

868,962 shs

Market Capitalization

$8.17 billion

P/E Ratio

68.99

Dividend Yield

N/A

Beta

0.49